Catalyst Wire Dossier Catalyst Wire Dossier

Huollingshengji granules

· Peking University Third Hospital
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Huollingshengji granules, covering 2021-07-08 to 2021-07-08. Get the full timeline:

Most recent: Clinical Trial Update: The Treatment of Amyotrophic Lateral Sclerosis With Huollingshengji Granules [Phase 2, Phase 3]

See pricing